B. Braun’s Introcan Safety® 3 Closed IV Catheter Receives Top Innovation Award
The only peripheral IV catheter where protection from needlesticks and blood exposure cannot be bypassed
Bethlehem, PA – January 22, 2013 – B. Braun Medical Inc. (B.Braun) announced today that its Introcan Safety® 3 Closed IV Catheter received a 2012 Top 20 Innovation Award from EMS World Magazine, the leading monthly publication for the emergency medical services market. In this month’s issue, Introcan Safety 3 is featured in an article on how it is improving the delivery of pre-hospital care by helping to reduce the risk of needlestick injuries and blood exposure, two major concerns that the EMS industry has been committed to addressing.
“We are proud to be recognized by EMS World Magazine for helping to protect the safety of EMS professionals throughout the U.S.,” said Tom Sutton, Vice President of Vascular Access Systems at B.Braun. “We are passionately committed to providing safety engineered IV therapy devices designed for optimum safety, which is especially important in the pre-hospital setting,” added Sutton.
From insertion to advancing the catheter to needle removal, the Introcan Safety 3 is designed to help protect healthcare workers and patients from needlestick injuries as the safety mechanism cannot be bypassed or activated inadvertently. The Introcan Safety 3 Closed IV Catheter offers an additional layer of safety and protection from blood borne pathogens with its multi-access blood control feature.
To read the full EMS World Magazine article, click here.
About B. Braun
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its “Sharing Expertise®” philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.
The B.Braun group of companies includes B.Braun, Aesculap® and CAPS®. B.Braun’s U.S. headquarters is located in Bethlehem, Pennsylvania, with its global headquarters based in Melsungen, Germany. It employs more than 44,000 employees in more than 50 countries throughout the world.